The group successfully won the bidding of Siwei (Shanghai) biological mRNA nucleic acid new crown vaccine project

Release time:

2021-05-19

The group successfully won the bidding of Siwei (Shanghai) biological mRNA nucleic acid new crown vaccine project

On May 19, the group company successfully won the bidding for the mRNA nucleic acid coronavirus project of Siwei (Shanghai) Biotechnology Co., Ltd in Jinqiao, Shanghai as the EPC general contractor. This is the third new coronavirus vaccine project that Jiangsu Qi 'an has won after the Conxino Coronavirus vaccine project and the Beijing Kexing Zhongwei Coronavirus vaccine project, which were developed by Chen Wei, an academician of the Chinese Academy of Engineering. Sinomicrobiology is an innovative mRNA drug research and development company. With a tight construction period and high professional quality requirements, Sinomicrobiology Group has successfully won the bidding for the mRNA nucleic acid new crown vaccine project through a joint venture with China Pharmaceutical Corporation. "Sinopharmaceutical Engineering" is the top domestic design institute, known as "quality from design"; The Jinhui Branch of the Group, which is responsible for the construction, has been committed to the domestic high-end biomedical engineering for a long time with excellent professional technology, and is good at providing value-added services and creating value for the owners through professional construction technology. Not long ago, Jinhui Branch completed four production lines of Sinovac New Coronavirus Vaccine ahead of schedule and won high praise from all sides. Xu Bin, the person in charge of Jinhui, said that it would fully carry forward the professional and technical advantages of Jiangsu Qi 'an and its experience in the construction of Sinovac vaccine project, work together with the "Chinese Medicine Project" for 95 days to ensure the completion of the construction task with high quality, and help the "Sibiome" contribute to the realization of human victory over COVID-19. (Jinhui Branch)

The group held a legal work exchange meeting

Nantong installation and construction enterprise high quality development seminar held in the group company

Recommended news

2026-06-05

The Group’s Roche Pharmaceutical Project has been awarded the One-Million-Safety-Hours Award.

On June 5, the Roche (Shanghai) Biopharmaceutical Production Base Project (Phase I) held a ceremony to celebrate reaching one million safe man-hours, and the Group was presented with a commemorative trophy.

2026-05-26

The Group convened a special meeting of the dedicated task force for major project services.

On the afternoon of May 25, the Group convened a special working meeting on major project services in the 16th-floor conference room, with senior management and all members of the Major Project Management Department in attendance. The meeting was chaired by Zhang Jian, General Manager of the Group.

2026-05-26

The Jinshun Branch of the Group organized a project management observation and exchange event.

On May 23, the Jinshun Branch of the Group organized an on-site observation and exchange session on project management. All project managers, frontline supervisors, and relevant personnel from various functional departments of the branch attended the event, while selected managers from China State Construction Engineering Corporation Third Bureau and Xinjiang Production and Construction Corps Construction Engineering Company were invited to participate in the observation and discussion.

2026-05-09

Group General Manager Zhang Jian Visits Asahi Kasei (Nantong) to Deepen Cooperation and Exchange

On May 8, Zhang Jian, General Manager of the Group, led a delegation to Asahi Kasei Fine Chemicals (Nantong) Co., Ltd. for a project follow-up visit and exchange meeting, during which they held a symposium with Asahi Kasei General Manager Yuichi Sanro and other senior executives. Cai Ting and Gao Mingmin, Deputy General Managers of the Group, also attended the event.

2026-05-21

The Group has won the bid for the Fujian Yuanfu Technology project to produce 3,000 tons per year of high-purity lithium fluoride.

Recently, good news emerged from the southern market: the Group has successfully won the bid for Fujian Yuanfu Technology Co., Ltd.’s 3,000-ton-per-year high-purity lithium fluoride project under an EPC general contracting model, with a total contract value exceeding RMB 40 million.

2026-05-19

The Shanghai Wangyuan Building Hotel’s comprehensive renovation project has entered its final sprint.

In mid-May, the hotel renovation project for the Shanghai Wangyuan Building, undertaken by the Group, entered its final, critical phase of intensive completion. At present, all core construction tasks— including the main interior finishing works and the installation and commissioning of various mechanical and electrical systems—have been successfully completed. The project’s focus has now fully shifted to meticulous fine‑tuning, integrated system testing and commissioning, and comprehensive on‑site cleanup and final finishing.